Restriction changes enable gynaecologists to administer botox for IOAB treatment

06 July 2017

As of 1 July 2017 restrictions as to who can administer intravesical injection of Botox® for the treatment of idiopathic overactive bladder (IOAB) under Medicare Benefits Schedule (MBS) item 18379 has changed. The new change enables gynaecologists to provide this service where it was previously restricted to urologists and urogynaecologists.
For any queries regarding the changes contact Mary Warner, Director of Medical Specialist Services at the Department of Health on (02) 6289 7315.



Reproductive Health Care Reform Bill 2019: proposed amendments

The proposed amendments call into question the standards and ethics of the medical profession, seeking to regulate and control practice.



Reproductive Health Care Reform Bill 2019

RANZCOG recognises the complexities associated with late term abortions, and supports a process by which late term abortions can be lawfully performed where appropriate.



Reproductive Health Care Reform Bill 2019

The peak body for obstetrics and gynaecology and women’s health, RANZCOG, welcomes the tabling of the Reproductive Health Care Reform Bill 2019 in the NSW Parliament and urges all MPs to vote in favour.